# Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients

> **NCT00373165** · PHASE4 · COMPLETED · sponsor: **Lower Saxony Center for Nephrology** · enrollment: 150 (—)

## Conditions studied

- DNA Virus Infection
- Herpesviridae Infections
- Cytomegalovirus Infection

## Interventions

- **DRUG:** Ganciclovir

## Key facts

- **NCT ID:** NCT00373165
- **Lead sponsor:** Lower Saxony Center for Nephrology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** 150 (—)
- **Last updated:** 2006-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00373165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00373165, "Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00373165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*